The Potential Effect of the IDH1 Mutation and MGMT Gene Promoter Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies

Objectives:(a) The objective of the study was to assess the control of seizure in glioblastoma patients receiving anti-epileptic drugs and chemotherapies after total resection and its association with O-methylguanine-DNA methyltransferase (MGMT) promoter methylation and the isocitrate dehydrogenase...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Maher KURDI, Nadeem Shafique BUTT, Saleh BAEESA, Badrah ALGHAMDI, Yazid MAGHRABI, Anas BARDEESI, Rothaina SAEEDI, Fahad ALGHAMDI, Najla ALGHANMI, Mohammed BARI, Alaa SAMKARI, Ahmed LARY, Taghreed ALSINANI, Sahar HAKAMY
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Turkish Epilepsy Society 2021-09-01
Seri Bilgileri:	Archives of Epilepsy
Konular:	anti-epileptic drugs epilepsy glioblastoma idh1 mutation mgmt promotor methylation temozolomide
Online Erişim:	http://archepilepsy.org/archives/archive-detail/article-preview/the-potential-effect-of-the-dh1-mutation-and-mgmt-/54631
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!